Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net earnings	$ 920	$ 932
Earnings from discontinued operations, net of tax	0	3
Earnings from continuing operations	920	929
Adjustments to reconcile earnings from continuing operations to net cash provided by operating activities:
Depreciation and amortization	336	344
Loss on extinguishment of debt	60	0
Gain on sale of other investments	(5)	(32)
Impairments and (gain)/loss on disposal of assets, net	(19)	10
Share-based compensation	80	72
Provision for bad debts	42	31
Change in operating assets and liabilities, net of effects from acquisitions:
Decrease/(increase) in trade receivables	(718)	1,473
Decrease/(increase) in inventories	(850)	350
Increase/(decrease) in accounts payable	1,657	(1,392)
Other accrued liabilities and operating items, net	169	23
Net cash provided by operating activities	1,672	1,808
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	(319)	(168)
Additions to property and equipment	(139)	(138)
Purchase of available-for-sale securities and other investments	(134)	(27)
Proceeds from sale of available-for-sale securities and other investments	129	47
Proceeds from maturities of available-for-sale securities	24	0
Proceeds from divestitures and disposal of held for sale assets	53	0
Net cash used in investing activities	(386)	(286)
Cash flows from financing activities:
Payment of contingent consideration obligation	(3)	0
Net change in short-term borrowings	(9)	65
Reduction of long-term obligations	(1,221)	(1)
Proceeds from long-term obligations, net of issuance costs	1,182	0
Net proceeds from issuance of common shares	59	219
Tax proceeds from share-based compensation	56	36
Dividends on common shares	(346)	(312)
Purchase of treasury shares	(686)	(389)
Net cash used in financing activities	(968)	(382)
Net increase in cash and equivalents	318	1,140
Cash and equivalents at beginning of period	2,865	1,901
Cash and equivalents at end of period	$ 3,183	$ 3,041